The downgrade from Outperform to Neutral by a prominent analyst could lead to a neutral short-term impact on TMHC's stock price as the market absorbs the news. The setting of a price target suggests a level that the analyst believes the stock will reach, which can influence investor expectations and stock performance. However, the impact may be moderated by market conditions and other factors affecting investor sentiment.